EUROPE HORMONE REPLACEMENT THERAPY MARKET 2021-2028

Lifesciences | Healthcare & Wellness

EUROPE HORMONE REPLACEMENT THERAPY MARKET 2021-2028

Market by Therapy Type, Type of Disease, Route of Administration, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s report, Europe’s hormone replacement therapy market is projected to gather a CAGR of 7.65% based on revenue during the assessed period of 2021-2028.


Report scope can be customized per your requirements. Request For Customization 

The countries examined in this market include:

•        The United Kingdom

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

The hormone replacement therapy market is envisioned to experience growth across the region due to factors such as a rise in the incidence rate of hormonal disorders among women. Along with this, the high prevalence of menopausal disorders, coupled with the increase in the geriatric population suffering from hypothyroidism, are likely to augment the demand for hormone replacement therapy across, thereby propelling the hormone replacement therapy market on a growth path.

In Germany, an initiative by EURORDIS known as the German Network of Pituitary Diseases and Adrenalopathy was established. Here, the organization’s primary aim is to connect patients with endocrinologists to address the treatment of diseases caused by hormonal insufficiencies. Moreover, the network helps in the distribution of guidelines among patients to educate them about preventive measures. Therefore, such initiatives are expected to increase the demand for hormone replacement therapy, simultaneously positioning the German hormone replacement therapy market on a growth path.

Furthermore, the Women’s Health Initiative study proved hormone therapy’s efficiency in preventing fractures related to osteoporosis. This factor primarily supports the market’s growth in France. Other than this, the health insurance fund in the country offers reimbursement of almost all medications used for hormone therapy, thereby driving the hormone replacement therapy market’s development across France.

Bayer AG is a pharmaceutical and chemical company specializing in general and specialty medicine. It offers a wide range of products, such as biotechnology products, agriculture chemicals, animal and human pharmaceuticals, and other products. Its product portfolio includes Mirena, which is a hormonal intrauterine device used for long-term birth control, as well as to treat heavy period flow. Founded in 1863, the company is headquartered in Leverkusen, Germany. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE HORMONE REPLACEMENT THERAPY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET

2.2. KEY INSIGHTS

2.2.1. INTRODUCTION OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT

2.2.2. MODERN SEDENTARY LIFESTYLES

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY STRATEGIC DEVELOPMENTS

2.6.1. ACQUISITIONS & MERGERS

2.6.2. PRODUCT LAUNCH & DEVELOPMENTS

2.6.3. CONTRACTS AND PARTNERSHIPS

2.6.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

2.7. MARKET DRIVERS

2.7.1. RISE IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE

2.7.2. INCREASE IN PREVALENCE OF HORMONAL DISORDERS

2.7.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS

2.8. MARKET RESTRAINTS

2.8.1. HIGH COST OF TREATMENT

2.8.2. ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY

2.9. MARKET OPPORTUNITIES

2.9.1. AVAILABILITY OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH

2.9.2. LAUNCH OF TELEMEDICINE CLINICAL PRACTICE SERVICES

3. EUROPE HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE

3.1. ESTROGEN HORMONE REPLACEMENT THERAPY

3.2. THYROID HORMONE REPLACEMENT THERAPY

3.3. TESTOSTERONE HORMONE REPLACEMENT THERAPY

3.4. HUMAN GROWTH HORMONE REPLACEMENT THERAPY

3.5. PROGESTOGEN HORMONE REPLACEMENT THERAPY

4. EUROPE HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE

4.1. MENOPAUSE

4.2. MALE HYPOGONADISM

4.3. GROWTH HORMONE DEFICIENCY

4.4. HYPOTHYROIDISM

4.5. OTHER TYPE OF DISEASES

5. EUROPE HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION

5.1. ORAL

5.2. PARENTERAL

5.3. TRANSDERMAL

5.4. OTHER ROUTES OF ADMINISTRATION

6. EUROPE HORMONE REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK

6.1. GERMANY

6.2. FRANCE

6.3. UNITED KINGDOM

6.4. ITALY

6.5. RUSSIA

6.6. SPAIN

6.7. REST OF EUROPE

7. COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. AMGEN

7.3. ANI PHARMACEUTICALS

7.4. BAYER AG

7.5. DR REDDY’S LABORATORIES LTD

7.6. ELI LILLY & COMPANY

7.7. GENENTECH INC

7.8. IPSEN

7.9. MERCK KGAA

7.10. NOVARTIS AG

7.11. NOVEN PHARMACEUTICALS INC

7.12. NOVO NORDISK A/S

7.13. PFIZER INC

7.14. TEVA PHARMACEUTICAL INDUSTRIES LTD

7.15. VIATRIS INC (MYLAN NV)

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       EUROPE HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       LIST OF ACQUISITIONS & MERGERS

TABLE 4:       LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 5:       LIST OF CONTRACTS AND PARTNERSHIPS

TABLE 6:       EUROPE HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 7:       EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 8:       EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 9:       EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     EUROPE HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)

FIGURE 3:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 4:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 5:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 6:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 7:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 8:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)

FIGURE 9:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

FIGURE 10:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

FIGURE 11:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

FIGURE 12:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

FIGURE 13:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)

FIGURE 14:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)

FIGURE 15:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

FIGURE 16:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

FIGURE 17:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

FIGURE 18:  EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

FIGURE 19:  GERMANY HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  FRANCE HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  ITALY HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  RUSSIA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  SPAIN HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  REST OF EUROPE HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;